$DANOY

Danone posts €6.708B Q1 revenue with 2.7% comparable growth. Company reaffirms 2026 guidance while pursuing strategic acquisitions including Huel and Arcor partnership.

Danone posted 2.7% Q1 growth with balanced volume and pricing gains, reaffirming 3-5% 2026 guidance while executing strategic shifts including Huel acquisition.

France's 2026 equities expected to concentrate on luxury, pharma, banking, and consumer staples giants despite moderate domestic growth.

Global regenerative agriculture market projected to grow from $3.86B in 2025 to $6.17B by 2030 at 9.78% CAGR, driven by startup-agribusiness alliances and data-driven solutions.

French biotech Standing Ovation raised $34.2M in Series B funding to expand precision fermentation dairy protein production, with Danone and Bel Group backing expansion.

Danone successfully raises €1.6 billion across three tranches with settlement in April 2026, signaling strong investor confidence in the food company's creditworthiness.

Danone successfully issued €1.6 billion in bonds across three tranches with 4-8 year maturities, demonstrating strong investor confidence and extending debt maturity profile.

Danone acquires Huel to strengthen functional nutrition presence, combining the brand's DTC capabilities with global distribution scale.

Danone acquires Huel to expand functional nutrition portfolio, combining direct-to-consumer expertise with global distribution capabilities.

Danone publishes 2025 Universal Registration Document, reporting 681.4 million shares and 721.3 million theoretical voting rights as of February 28, 2026.

Danone publishes 2025 financial statements, disclosing 681.4 million total shares and detailed voting rights metrics as of February 28, 2026.

Portnoy Law Firm investigates Danone for securities fraud following infant formula contamination, with stock falling 10.65% over two trading days.

Global digestive health supplements market expected to double to $25.83 billion by 2035, driven by rising GI disorders and preventive healthcare trends, though regulatory challenges persist.

Law firm launches securities probe into Danone after toxin found in infant formula triggers product recalls and stock declines of over 10%.

Law firm investigates Danone for securities fraud over contaminated infant formula from Thailand. Stock fell nearly 11% following disclosure of toxic bacterial contamination in formula batches.